甲胎蛋白检测在肝癌早期诊断上取得了重大突破,然而在门诊所见到的,绝大多数属不能手术切除的中、晚期患者。当前对中、晚期肝癌的治疗,仍然具有重要现实意义。随着基础和临床研究的发展,对肝癌血液供应特 Alpha-fetoprotein detection has made a major breakthrough in the early diagnosis of liver cancer. However, the vast majority of patients seen at the clinic are middle- and late-stage patients who cannot undergo surgical resection. The current treatment of middle and late stage liver cancer still has important practical significance. With the development of basic and clinical research, the blood supply to liver cancer is special.